OTHER FINANCIAL INFORMATION (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Other Financial Information [Abstract] |
|
| Summary of Accounts Receivable, Net |
The following table summarizes our Accounts receivable, net: | | | | | | | | | | | | | | | | (in millions) | | June 30, 2026 | | December 31, 2025 | Accounts receivable(1) | | $ | 5,902 | | | $ | 5,895 | | | Less: allowances for chargebacks | | (671) | | | (843) | | | Less: allowances for cash discounts and other | | (125) | | | (97) | | | Less: allowances for credit losses | | (51) | | | (41) | | | Accounts receivable, net | | $ | 5,055 | | | $ | 4,913 | | _______________________________(1) As of June 30, 2026, the majority of our Accounts receivable balance arises from product sales in the U.S. and Europe and approximately 60% relates to three wholesalers—Cardinal Health, Inc., Cencora, Inc. and McKesson Corporation—and their specialty distributor affiliates.
|
| Summary of Inventories |
The following table summarizes our Inventories: | | | | | | | | | | | | | | | | (in millions) | | June 30, 2026 | | December 31, 2025 | | Raw materials | | $ | 1,415 | | | $ | 1,414 | | | Work in process | | 1,163 | | | 1,306 | | | Finished goods | | 1,719 | | | 1,647 | | | Total | | $ | 4,298 | | | $ | 4,368 | | | Reported as: | | | | | | Inventories | | $ | 1,953 | | | $ | 1,774 | | Other long-term assets(1) | | 2,345 | | | 2,594 | | | Total | | $ | 4,298 | | | $ | 4,368 | |
_______________________________ (1) As of June 30, 2026, this amount primarily consists of raw materials and work in process.
|
| Summary of Property, Plant and Equipment, Net |
The following table summarizes our Property, plant and equipment, net: | | | | | | | | | | | | | | | | (in millions) | | June 30, 2026 | | December 31, 2025 | | Property, plant and equipment | | $ | 8,707 | | | $ | 8,302 | | | Less: accumulated depreciation | | (2,874) | | | (2,696) | | | Property, plant and equipment, net | | $ | 5,833 | | | $ | 5,606 | |
The following table summarizes Depreciation expense: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, | | June 30, | | (in millions) | | 2026 | | 2025 | | 2026 | | 2025 | | Depreciation expense | | $ | 98 | | | $ | 93 | | | $ | 191 | | | $ | 190 | |
|
| Summary of Changes in Accumulated Other Comprehensive Income |
The following tables summarize the changes in Accumulated other comprehensive income by component, net of tax: | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Foreign Currency Translation | | Available-for-Sale Debt Securities | | Cash Flow Hedges | | Total | | Balance as of March 31, 2026 | | $ | 64 | | | $ | (3) | | | $ | 18 | | | $ | 78 | | Net unrealized (loss) gain, net of income tax expense of $0, $0, and $2, respectively | | (18) | | | 1 | | | 16 | | | (1) | | Loss reclassified to net income, net of income tax benefit of $0, $0, and $(2), respectively | | — | | | 2 | | | 16 | | | 18 | | | Other comprehensive (loss) income, net | | (18) | | | 3 | | | 32 | | | 17 | | | Balance as of June 30, 2026 | | $ | 46 | | | $ | — | | | $ | 49 | | | $ | 95 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Foreign Currency Translation | | Available-for-Sale Debt Securities | | Cash Flow Hedges | | Total | | Balance as of December 31, 2025 | | $ | 74 | | | $ | 8 | | | $ | (43) | | | $ | 39 | | Net unrealized (loss) gain, net of income tax expense (benefit) of $0, $(3), and $8, respectively | | (28) | | | (9) | | | 56 | | | 19 | | Loss reclassified to net income, net of income tax benefit of $0, $0, and $(5), respectively | | — | | | — | | | 37 | | | 37 | | | Other comprehensive (loss) income, net | | (28) | | | (8) | | | 92 | | | 56 | | | Balance as of June 30, 2026 | | $ | 46 | | | $ | — | | | $ | 49 | | | $ | 95 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Foreign Currency Translation | | Available-for-Sale Debt Securities | | Cash Flow Hedges | | Total | | Balance as of March 31, 2025 | | $ | 54 | | | $ | — | | | $ | 38 | | | $ | 92 | | Net unrealized gain (loss), net of income tax expense (benefit) of $0, $1, and $(21), respectively | | 51 | | | 4 | | | (149) | | | (94) | | Loss (gain) reclassified to net income, net of income tax expense (benefit) of $0, $0, and $2, respectively | | — | | | — | | | (16) | | | (16) | | | Other comprehensive income (loss), net | | 51 | | | 4 | | | (166) | | | (111) | | | Balance as of June 30, 2025 | | $ | 105 | | | $ | 4 | | | $ | (127) | | | $ | (18) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Foreign Currency Translation | | Available-for-Sale Debt Securities | | Cash Flow Hedges | | Total | | Balance as of December 31, 2024 | | $ | 36 | | | $ | — | | | $ | 96 | | | $ | 132 | | Net unrealized gain (loss), net of income tax expense (benefit) of $0, $1, and $(27), respectively | | 69 | | | 4 | | | (189) | | | (116) | | Loss (gain) reclassified to net income, net of income tax expense (benefit) of $0, $0, and $5, respectively | | — | | | — | | | (35) | | | (35) | | | Other comprehensive income (loss), net | | 69 | | | 4 | | | (224) | | | (150) | | | Balance as of June 30, 2025 | | $ | 105 | | | $ | 4 | | | $ | (127) | | | $ | (18) | |
|
| Reclassification out of Accumulated Other Comprehensive Income |
The following table summarizes the reclassifications out of Accumulated other comprehensive income and into Net (loss) income, including the affected line items from our Condensed Consolidated Statements of Operations: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | | | June 30, | | June 30, | | | | (in millions) | | 2026 | | 2025 | | 2026 | | 2025 | | Line Item Affected | | Net (loss) gain related to cash flow hedges | | $ | (18) | | | $ | 19 | | | $ | (42) | | | $ | 40 | | | Product sales | | Net loss related to available-for-sale debt securities | | $ | 2 | | | $ | — | | | $ | — | | | $ | — | | | Other (income) expense, net | | Income tax (benefit) expense | | $ | (2) | | | $ | 2 | | | $ | (5) | | | $ | 5 | | | Income tax expense |
|
| Summary of Restructuring Charges |
The following table summarizes the affected line items from our Condensed Consolidated Statements of Operations: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, | | June 30, | | (in millions) | | 2026 | | 2025 | | 2026 | | 2025 | | Research and development expenses | | $ | 2 | | | $ | 6 | | | $ | 17 | | | $ | 44 | | | Selling, general and administrative expenses | | 15 | | | 7 | | | 40 | | | 43 | | | Restructuring charges | | $ | 17 | | | $ | 13 | | | $ | 57 | | | $ | 88 | |
|
| Summary of Other (Income) Expense, Net |
The following table summarizes the components of Other (income) expense, net: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, | | June 30, | | (in millions) | | 2026 | | 2025 | | 2026 | | 2025 | | (Gain) loss from equity securities, net | | $ | (343) | | | $ | (142) | | | $ | (485) | | | $ | 284 | | | Interest income | | (45) | | | (73) | | | (140) | | | (166) | | | Other, net | | 1 | | | 6 | | | 3 | | | 2 | | | Other (income) expense, net | | $ | (387) | | | $ | (208) | | | $ | (621) | | | $ | 120 | |
|